Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Geissler

Showing results (51-60 of 449) with videos related to

Pageof 45
Sort By:
Transplantation|April 14, 2020
Transplantation Direct: TTS eJournal Progress UpdateEdward K Geissler, Jeremy R Chapman
Journal of Fish Diseases|December 5, 2003
SDS-PAGE and Western blot analysis of triactinomyxon spores of Myxobolus cerebralis, the cause of whirling disease in salmonid fishH Soliman, K Geissler, M El-Matbouli
The New England Journal of Medicine|August 6, 1992
Functional asplenia and vasculitis associated with antineutrophil cytoplasmic antibodiesG Sunder-Plassmann, K Geissler, E Penner
Oncoimmunology|November 22, 2012
Friend or foe: A novel role of β-defensins in tumor developmentJohann Röhrl, Edward K Geissler, Thomas Hehlgans
Clinical & Experimental Metastasis|February 5, 2009
Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategiesGudrun E Koehl, Andreas Gaumann, Edward K Geissler
Current Opinion in Organ Transplantation|December 22, 2011
Human regulatory macrophages as a cell-based medicinal productJames A Hutchinson, Paloma Riquelme, Edward K Geissler
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivoE K Geissler, M N Scherer, C Graeb
Transplantation|October 6, 1997
Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responsesE K Geissler, W J Korzun, C Graeb
Transplantation Research|February 2, 2013
Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCsPaloma Riquelme, Edward K Geissler, James A Hutchinson
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
mTOR, cancer and transplantationEdward K Geissler, Hans J Schlitt, George Thomas
Pageof 45

Showing results (51-60 of 449) with videos related to

Sort By:
Pageof 45
Transplantation|April 14, 2020
Transplantation Direct: TTS eJournal Progress UpdateEdward K Geissler, Jeremy R Chapman
Journal of Fish Diseases|December 5, 2003
SDS-PAGE and Western blot analysis of triactinomyxon spores of Myxobolus cerebralis, the cause of whirling disease in salmonid fishH Soliman, K Geissler, M El-Matbouli
The New England Journal of Medicine|August 6, 1992
Functional asplenia and vasculitis associated with antineutrophil cytoplasmic antibodiesG Sunder-Plassmann, K Geissler, E Penner
Oncoimmunology|November 22, 2012
Friend or foe: A novel role of β-defensins in tumor developmentJohann Röhrl, Edward K Geissler, Thomas Hehlgans
Clinical & Experimental Metastasis|February 5, 2009
Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategiesGudrun E Koehl, Andreas Gaumann, Edward K Geissler
Current Opinion in Organ Transplantation|December 22, 2011
Human regulatory macrophages as a cell-based medicinal productJames A Hutchinson, Paloma Riquelme, Edward K Geissler
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivoE K Geissler, M N Scherer, C Graeb
Transplantation|October 6, 1997
Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responsesE K Geissler, W J Korzun, C Graeb
Transplantation Research|February 2, 2013
Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCsPaloma Riquelme, Edward K Geissler, James A Hutchinson
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
mTOR, cancer and transplantationEdward K Geissler, Hans J Schlitt, George Thomas
Pageof 45